An increase in serum carcinoembryonic antigen (CEA) and carbohydrate antigen 19‐9 (CA19‐9) has been associated with tumor progression and decreased overall survival of colorectal cancer.5 The gene discussed is CEACAM5; the disease is neoplasm.